Published Online December 7, 2006
Science DOI: 10.1126/science.1136699
http://www.sciencemag.org/cgi/content/abstract/1136699v1



"Secondary siRNAs Result from Unprimed RNA Synthesis and Form a Distinct Class".

Titia Sijen 1, Florian A. Steiner 1, Karen L. Thijssen1 , and Ronald H. A. Plasterk 1, *

1 Hubrecht Laboratory (NIOB-KNAW), Uppsalalaan 8, 3584 CT, the Netherlands.

* To whom correspondence should be addressed.
Ronald H. A. Plasterk , E-mail: plasterk@niob.knaw.nl



Abstract:
Supporting Online Material:
Figure S4: Model for transitive RNAi and secondary siRNA production.
Additional References:
Further Topics:
Other Links:
Further Information:




Abstract:

In C. elegans, an effective RNA interference (RNAi) response requires the production of secondary siRNAs by RNA-directed RNA polymerases (RdRPs). We cloned secondary siRNAs from transgenic C. elegans lines expressing a single 22 nucleotide primary siRNA. Several secondary siRNAs start a few nucleotides downstream of the primary siRNA, indicating that non-RISC (RNA-induced silencing complex) cleaved mRNAs are substrates for secondary siRNA production. In lines expressing primary siRNAs with single-nucleotide mismatches, secondary siRNAs do not carry the mismatch, but contain the nucleotide complementary to the mRNA. We infer that RdRPs perform unprimed RNA synthesis. Secondary siRNAs are only of antisense polarity, carry 5' di- or triphosphates and are only in minority associated with RDE-1, the RNAi-specific argonaute protein. Therefore, secondary siRNAs represent a distinct class of small RNAs. Their biogenesis depends on RdRPs, and we propose that each secondary siRNA is an individual RdRP product.




Supporting Online Material:

http://www.sciencemag.org/cgi/content/full/sci;1136699/DC1

Materials and Methods
Figs. S1 to S4
Tables S1 and S2
References




Figure S4: Model for transitive RNAi and secondary siRNA production.




Additional References:

1. Pak J, and Fire A,
"Distinct Populations of Primary and Secondary Effectors During RNAi in C. elegans".

2. Li L-C, Okino ST, Zhao H, Pookot D, Place RF, Urakami S, Enokida H, and Dahiya R,
"Small dsRNAs induce transcriptional activation in human cells".

3. Pennacchio LA, Ahituv N, Moses AM, Prabhakar S, Nobrega MA, Shoukry M, Minovitsky S, Dubchak I, Holt A, Lewis KD, Plajzer-Frick I, Akiyama J, De Val S, Afzal V, Black BL, Couronne O, Eisen MB, Visel A, and Rubin EM, "In vivo enhancer analysis of human conserved non-coding sequences".

4. Pollard KS, Salama SR, Lambert N, Lambot M-A, Coppens S, Pedersen JS, Katzman S, King B, Onodera C, Siepel A, Kern AD, Dehay C, Igel H, Ares M Jr, Vanderhaeghen P, and Haussler D,
"An RNA gene expressed during cortical development evolved rapidly in humans".



Links to RNA and Biological Causality:

A Brief History of  Activator RNA:



Further Topics in:  Euchromatin,  active DNA, and  RNA  ribo-regulators:

Links to Euchromatin Activator RNA Reviews:
Links to Euchromatin Activator RNA Research:
Links to Ultrastructural Probes of DNase I-Sensitive Sites:
Links to RNA as a Therapeutic Agent:
Links to Hodgkin Lymphoma Immuno-Pathology:
Links to Activated T-Lymphocyte Immunotherapy:
Links to Medical Systems Biology:
Links to Selective Gene Transcription:
Links to RNA-Induced Epigenetics:
Links to RNA-Induced Embryogenesis:
Links to RNA and Biological Causality:
Links to Reprogramming and Neoplasia:

"Ultrastructural Probes of Active DNA Sites, and the RNA Activators of DNA".




Top of Page - Euchromatin Network - Current Research - Forums - Other Sites - Future Events -


For Further Information and Feedback:
Phone:  +1 650 367 6483
E-mail: frenster@euchromatin.net



euchromatin: "the most active portion of the genome within the cell nucleus".